Design Therapeutics (DSGN) Stock Price, Quote, News & History | Benzinga

Design Therapeutics Inc (DSGN) Stock Price, Quote, News & History

DSGNNASDAQ

Trade with Public

Trade with Public

$10.27

-0.17-1.63%

Last update: Jun 2, 3:26 PM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$10.30

Close

-

Volume / Avg.

728.73K / 661.18K

Day Range

$9.87 - $10.39

52 Wk Range

3.33 - 17.25

Market Cap

$641.43M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

6.16%

Days to Cover

5.34

Recent Design Therapeutics Inc News

Design Therapeutics Stock Wobbles After Rare Genetic Disease Data

Design Therapeutics reported Phase 1/2 data for DT-216P2, showing biomarker and clinical improvements in Friedreich ataxia patients.

Vandana Singh

Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller

Billionaire hedge fund manager Steven Cohen is diving into small-cap biotech with new stakes in two clinical-stage companies, signaling confidence in their potential for outsized returns.

Surbhi Jain

Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch

All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-54.00M

Investing Cash Flow (TTM)

7.45M

Financing Cash Flow (TTM)

45.65M

Free Cash Flow (TTM)

-54.12M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-897.00K

Analyst Trends and Forecast

1

Dec 25

1

Jan

2

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$433.84M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.00

Earnings Yield % (TTM)

-11.46%

Earnings Yield % (FWD)

-13.13%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.49

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.77M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$10.30

Close

-

Volume / Avg.

728.73K / 661.18K

Day Range

$9.87 - $10.39

52 Wk Range

3.33 - 17.25

Market Cap

$641.43M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

6.16%

Days to Cover

5.34

About

Sector

Health Care

Industry

Biotechnology

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifyin...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Design Therapeutics (DSGN) stock?

A

You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Design Therapeutics (DSGN) competitors?

A

There are no as such competitors for Design Therapeutics.

Q

What is the forecast, or price target, for Design Therapeutics (DSGN) stock?

A

Design Therapeutics has a consensus price target of $13.13.

Q

What is the current price for Design Therapeutics (DSGN)?

A

The stock price for Design Therapeutics (NASDAQ: DSGN) is $10.27 last updated June 2, 2026 at 3:26 PM EDT.

Q

Does Design Therapeutics (DSGN) pay a dividend?

A

There are no upcoming dividends for Design Therapeutics.

Q

When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?

A

Design Therapeutics does not have any upcoming earnings scheduled.

Q

Is Design Therapeutics (DSGN) going to split?

A

There is no upcoming split for Design Therapeutics.

Q

What sector and industry does Design Therapeutics (DSGN) operate in?

A

Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.